Results 31 to 40 of about 4,784 (224)

The Addition of Dydrogesterone after Frozen Embryo Transfer in Hormonal Substituted Cycles with Low Progesterone Levels [PDF]

Revista Brasileira de Ginecologia e Obstetrícia, 2023
Objective To determine whether a rescue strategy using dydrogesterone (DYD) could improve the outcomes of frozen embryo transfer cycles (FET) with low progesterone (P4) levels on the day of a blastocyst transfer.
Jose Metello, Claudia Tomas, Pedro Ferreira, Samuel Santos-Ribeiro   +3 more
doaj   +1 more source

A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial [PDF]

, 2016
BACKGROUND: Miscarriage is a common complication of pregnancy occurring in 15-20 % of all clinically recognized pregnancies. Currently, there is still no good scientific evidence to support the routine use of progestogens for the treatment of ...
Chan, MKD, Cheung, KW, Lee, VCY, Li, RHW, Ng, EHY, Yung, SF   +5 more
core   +1 more source

Treatment of symptoms of the menopause: an endocrine society clinical practice guideline [PDF]

, 2015
Objective: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. Participants: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and
Davis, Susan R., Gompel, Anne, Lumsden, Mary Ann, Murad, M. Hassan, Pinkerton, JoAnn V., Santen, Richard J., Stuenkel, Cynthia A.   +6 more
core   +1 more source

Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo‐controlled trial

BMC Pregnancy and Childbirth, 2021
Background Preterm birth is a major challenge in obstetric and perinatal care. It is the leading cause of neonatal death. The primary aim of this study was to evaluate the efficacy of oral dydrogesterone on latency period in managing preterm labor.
Suparudeewan Thongchan, Vorapong Phupong
doaj   +1 more source

Randomized Clinical Trial Comparing Oral Dydrogesterone to Micronized Vaginal Progesterone for Endometrial Preparation in Frozen-Thawed Embryo Transfer Cycle

Clinical and Experimental Obstetrics & Gynecology, 2023
Background: The objective was to compare the use of micronized vaginal progesterone 800 mg daily and oral dydrogesterone 40 mg daily in the endometrial preparation for frozen-thawed embryo transfer (FET).
Luma Caroline Gomes Mattos de Macedo, Mario Cavagna Neto, Artur Dzik, Andressa do Rosário Rocha, Sônia Maria Rolim Rosa Lima   +4 more
doaj   +1 more source

Effect of Dydrogesterone on the Outcome of Idiopathic Intrauterine Growth Restriction: A Double-blind Clinical Trial Study

Advanced Biomedical Research, 2018
Background: The aim of this study was to evaluate the effect of dydrogesterone in the outcome of idiopathic intrauterine growth restriction (IUGR). Materials and Methods: It is a double-blind randomized control clinical trial study that was done in ...
Elaheh Zarean, Fatemeh Mostajeran, Zahra Dayani   +2 more
doaj   +1 more source

Hormone replacement therapy [PDF]

, 2012
Martha Hickey, Jane Elliott, Sonia Louise ...
Davison, S., Elliott, C., Hickey, M.
core   +2 more sources

An assessment of the efficacy and safety of dydrogesterone in women with ovarian endometrioma: An open‐label multicenter clinical study

Reproductive Medicine and Biology, 2021
Purpose To assess the efficacy and safety of dydrogesterone in Japanese women with ovarian endometrioma in a real‐world setting. Methods The post‐marketing study involved 15 sites in Japan.
Jo Kitawaki, Kaori Koga, Takumi Kanzo, Mikio Momoeda   +3 more
doaj   +1 more source

Prescribing patterns in premenstrual syndrome [PDF]

, 2002
Background Over 300 therapies have been proposed for premenstrual syndrome. To date there has been only one survey conducted in the UK of PMS treatments prescribed by GPs, a questionnaire-based study by the National Association of Premenstrual Syndrome ...
Katrina M Wyatt, Paul W Dimmock, Martin Frischer, Paul W Jones, Shaugn PM O'Brien, GR Kraemer, SR Johnson, ZH Chakmakjian, KM Wyatt, RH Corney, TR Hylan, KE Lyon, A Stewart, Joint Food Safety and Standards Group., JR Lee, J Hollowell, J Barnes, KM Wyatt, K Dalton, CP West, RA Lawrenson, PW Dimmock, KM Wyatt, JF Mortola, L Plouffe, EW Freeman, CM Harris, DCG Skegg   +27 more
core   +2 more sources

Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase) [PDF]

Human Reproduction Open
Pietro Santulli, Mathilde Bourdon, Jean-Marc Treluyer   +2 more
exaly   +2 more sources